Targeted Therapeutics in Melanoma (Current Clinical Oncology)

Humana Press
Wo zu kaufen (2) Eigenschaften
Gesponsert
Targeted Therapeutics in Melanoma (Current Clinical Oncology)
Medimops DE
138.98 EUR
Preis aktualisiert am: 14-06-2026 05:46:56
Siehe Produktangebot
Gesponsert
Targeted Therapeutics in Melanoma
SpringerLink DE
160.49 EUR
Preis aktualisiert am: 13-06-2026 18:04:30
Siehe Produktangebot

Allgemein

Marke
Springer-Verlag GmbH
MPN
Springer-Verlag GmbH 15438464
ISBN
Springer-Verlag GmbH 1617794066

Eigenschaften

Ähnliche Produkte

Targeted Therapeutics in Melanoma (Current Clinical Oncology)
Targeted Therapeutics in Melanoma (Current Clinical Oncology)
Produkt anzeigen
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas (Resistance to Targeted Anti-Cancer Therapeutics, Band 17)
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas (Resistance to Targeted Anti-Cancer Therapeutics, Band 17)
Produkt anzeigen
Resistance to Ibritumomab in Lymphoma (Resistance to Targeted Anti-Cancer Therapeutics, Band 18)
Resistance to Ibritumomab in Lymphoma (Resistance to Targeted Anti-Cancer Therapeutics, Band 18)
Produkt anzeigen
Melanoma: Biologically Targeted Therapeutics (Current Clinical Oncology)
Melanoma: Biologically Targeted Therapeutics (Current Clinical Oncology)
Produkt anzeigen
Resistance to Immunotherapeutic Antibodies in Cancer: Strategies to Overcome Resistance (Resistance to Targeted Anti-Cancer Therapeutics)
Resistance to Immunotherapeutic Antibodies in Cancer: Strategies to Overcome Resistance (Resistance to Targeted Anti-Cancer Therapeutics)
Produkt anzeigen
Resistance to Photodynamic Therapy in Cancer
Resistance to Photodynamic Therapy in Cancer
Produkt anzeigen
Menü